Threshold Pharmaceuticals, Inc. THLD
No live quote for THLD yet.
Analyst view
Consensus: hold
Hold
Price target (mean) 0.70
- Target (low)
- 0.40
- Target (mean)
- 0.70
- Target (high)
- 1.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 3
- 2 months ago 3
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.07 | -0.07 – -0.07 | -0.10 | +30.0% | 0 | 0.0% | 1 |
| Next quarter | -0.07 | -0.07 – -0.07 | -0.08 | +12.5% | 0 | 0.0% | 1 |
| Current year | -0.29 | -0.29 – -0.29 | -0.34 | +14.7% | 0 | 0.0% | 1 |
| Next year | -0.39 | -0.39 – -0.39 | -0.29 | -34.5% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 8, 2014 | Cantor Fitzgerald | Initiated | — | Buy |
| Sep 4, 2014 | H.C. Wainwright | Initiated | — | Buy |
| Feb 19, 2013 | PiperJaffray | Upgrade | — | Overweight |
| Jan 16, 2013 | PiperJaffray | Initiated | — | Neutral |
| Nov 20, 2012 | Brean Capital | Initiated | — | Buy |
| Sep 19, 2012 | Maxim Group | Initiated | — | Buy |
| Aug 23, 2012 | Stifel Nicolaus | Initiated | — | Buy |